Search - tctmd.com

Displaying 581 - 600 of 3240

Sort: Relevancy | Date

Presentation NY Valves 2024

"Challenge Is Inevitable But Defeat Is Optional" – A Case of TAVR in Very Small Anatomy With an Anomalous Origin of Both Coronary Arteries From a Single Sinus

Presenter: Prashant Dwivedi

June 05, 2024

Presentation NY Valves 2024

TAVR in Extremely Horizontal Anatomy

Presenter: Rajneesh Kapoor

June 05, 2024

Presentation NY Valves 2024

Pericardial Effusion After TAVR: Percutaneous Treatment Strategies

Presenter: Thomas E. Waggoner

June 05, 2024

Presentation NY Valves 2024

TAVR in a Patient With an Exophytic STJ Calcium Shelf Using a BEV and Two-Stage Inflation

Presenter: Keaton Nasser

June 05, 2024

Presentation NY Valves 2024

The Promise of Next Generation Cerebral Embolic Protection Devices

Presenter: Tamim M. Nazif

June 05, 2024

Presentation NY Valves 2024

Modern Era Clinical Trial Strategies For Cerebral Embolic Protection Devices

Presenter: Alexandra J. Lansky

June 05, 2024

Presentation NY Valves 2024

Practical Considerations for Post-TAVR Stroke Therapy

Presenter: Axel Linke

June 05, 2024

Presentation NY Valves 2024

Practical Tips for Cerebral Embolic Protection: From Clinical Trials to Clinical Practice

Presenter: Amar Krishnaswamy

June 05, 2024

Presentation NY Valves 2024

Innovation in TAVR for Pure AR (J Valve)

Presenter: Tsuyoshi Kaneko

June 05, 2024

Presentation NY Valves 2024

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

Presenter: Rebecca T. Hahn

June 05, 2024

Presentation NY Valves 2024

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Presenter: Neel Butala

June 05, 2024

Presentation NY Valves 2024

Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial

Presenter: Howard C. Herrmann

June 05, 2024

Presentation NY Valves 2024

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Presenter: Ole De Backer

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement Among Patients Receiving Renal Dialysis

Presenter: Chloe Kharsa

June 05, 2024

Presentation NY Valves 2024

Impact of Pulmonary Hypertension on Transcatheter Aortic Valve Replacement Outcomes: A Large Cohort Analysis

Presenter: Samarthkumar Thakkar

June 05, 2024

Presentation NY Valves 2024

Chronic Kidney Disease and In-hospital Outcomes in TAVR Patients

Presenter: Sabina Kumar

June 05, 2024

Presentation NY Valves 2024

Impact of Surgical or Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis on Perioperative Outcomes in Patients Undergoing Noncardiac Surgery

Presenter: Kitae Kim

June 05, 2024

Presentation NY Valves 2024

Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement

Presenter: Daijiro Tomii

June 05, 2024

Presentation NY Valves 2024

Pre-Existing Thoracic Aortic Aneurysm is Associated with Type A Aortic Dissections After Transcatheter Aortic Valve Replacement

Presenter: Tyler Bauer

June 05, 2024

Presentation NY Valves 2024

Impact of Atherosclerotic Disease Extent on Clinical Outcomes in Female Patients Undergoing TAVI: A Report From the WIN-TAVI Registry

Presenter: Benjamin Bay

June 05, 2024

Advertisement

"Challenge Is Inevitable But Defeat Is Optional" – A Case of TAVR in Very Small Anatomy With an Anomalous Origin of Both Coronary Arteries From a Single Sinus

TAVR in Extremely Horizontal Anatomy

Pericardial Effusion After TAVR: Percutaneous Treatment Strategies

TAVR in a Patient With an Exophytic STJ Calcium Shelf Using a BEV and Two-Stage Inflation

The Promise of Next Generation Cerebral Embolic Protection Devices

Modern Era Clinical Trial Strategies For Cerebral Embolic Protection Devices

Practical Considerations for Post-TAVR Stroke Therapy

Practical Tips for Cerebral Embolic Protection: From Clinical Trials to Clinical Practice

Innovation in TAVR for Pure AR (J Valve)

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Transcatheter Aortic Valve Replacement Among Patients Receiving Renal Dialysis

Impact of Pulmonary Hypertension on Transcatheter Aortic Valve Replacement Outcomes: A Large Cohort Analysis

Chronic Kidney Disease and In-hospital Outcomes in TAVR Patients

Impact of Surgical or Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis on Perioperative Outcomes in Patients Undergoing Noncardiac Surgery

Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement

Pre-Existing Thoracic Aortic Aneurysm is Associated with Type A Aortic Dissections After Transcatheter Aortic Valve Replacement

Impact of Atherosclerotic Disease Extent on Clinical Outcomes in Female Patients Undergoing TAVI: A Report From the WIN-TAVI Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content